David B. Pendarvis was elected to the Board of Directors in 2017. Mr. Pendarvis served as chief administrative officer of ResMed Inc. from 2011 to 2023 and held various other leadership roles at ResMed Inc. since 2002. From 2000 until 2002 Mr. Pendarvis was a partner at Gray Cary Ware & Friedenrich (presently, DLA Piper). From 1986 until 2000 he was an associate (1986-1992) and a partner (1993-2000) at Gibson, Dunn & Crutcher, and from 1984 until 1986 he served as a law clerk to United States District Court Judge, J. Lawrence Irving in the United States District Court, San Diego. Mr. Pendarvis served as a director of Sequenom, Inc. from 2009 until its acquisition by Laboratory Corporation of America Holdings in 2016. His legal expertise and experience as general counsel with global responsibilities will provide the Board of Directors with valuable perspective for risk oversight.